187 related articles for article (PubMed ID: 14252013)
1. [MYDOCALM TREATMENT OF PSEUDO-PARKINSON DISORDERS FOLLOWING THE ADMINISTRATION OF NEUROLEPTIC AGENTS].
BLONDEL F; COULEON M; COULEON H; ANNE L; CLERC G; COULOMBIER J; TRENQUALYEJP DE
Ann Med Psychol (Paris); 1964 Dec; 122():755-8. PubMed ID: 14252013
[No Abstract] [Full Text] [Related]
2. [PRELIMINARY CLINICAL EVALUATION OF RO 5-3608. COMPARISON WITH TRIHEXAPHENIDYL IN MEDICINAL PARKINSONISM].
MADALENA JC
Folha Med; 1965 Feb; 50():119-23. PubMed ID: 14347357
[No Abstract] [Full Text] [Related]
3. [EXPERIENCE WITH A MYOTONOLYTIC (MYDOCALM) IN THE TREATMENT OF ARTERIAL OCCLUSIVE DISEASE OF THE EXTREMITIES].
LINKE H
Wien Med Wochenschr; 1964 May; 114():314-20. PubMed ID: 14232726
[No Abstract] [Full Text] [Related]
4. [THE INFLUENCE OF ACTION OF ANTINEUROLEPTIC DRUGS ON THE NEUROLEPTIC THRESHOLD].
HAASE HJ; ZAHN M; ZSCHUCKE CF
Int J Neuropsychiatry; 1965; 1():239-52. PubMed ID: 14309089
[No Abstract] [Full Text] [Related]
5. [EXPERIMENTS WITH THE ANTI-PARKINSON AGENT BENZTROPINE RECENTLY INTRODUCED IN FRANCE].
SCHEWEICH M; POYART E; BAIL P; LOUIS MC
Ann Med Psychol (Paris); 1963 Dec; 121():771-8. PubMed ID: 14101924
[No Abstract] [Full Text] [Related]
6. PROPHYLACTIC TREATMENT OF PHENOTHIAZINE-INDUCED EXTRAPYRAMIDAL EFFECTS.
GOLDSTEIN BJ; JORDAN JA; COLEMAN B
J Fla Med Assoc; 1964 Dec; 51():775-8. PubMed ID: 14232347
[No Abstract] [Full Text] [Related]
7. Parkinsonism and the use of tranquilizers.
GOWDEY CW; FORSTER KS
Can Psychiatr Assoc J; 1961 Mar; 6():79-87. PubMed ID: 13707566
[No Abstract] [Full Text] [Related]
8. [AKINETON IN PARKINSONISM CAUSED BY DRUGS].
ALLEVA PM
Ther Ggw; 1963 Dec; 102():1494-6. PubMed ID: 14112744
[No Abstract] [Full Text] [Related]
9. [Drug-induced parkinsonism and its treatment with Akineton].
ROSEN A
Ther Umsch; 1963 Jan; 20():9-12. PubMed ID: 13974823
[No Abstract] [Full Text] [Related]
10. [Mydocalm, a new drug to relax spastic muscles in neurological diseases].
LEHOCZKY T
Ther Hung; 1961; 9():10-3. PubMed ID: 13929385
[No Abstract] [Full Text] [Related]
11. CURRENT VIEWS CONCERNING THE ETIOLOGY, PATHOPHYSIOLOGY, AND TREATMENT OF PARKINSON'S DISEASE.
MEYER JS; MAGEE KR
J Neuropsychiatr; 1964 Jun; 5():284-90. PubMed ID: 14167691
[No Abstract] [Full Text] [Related]
12. TRIPERIDOL (A PRELIMINARY REPORT).
O'REILLY PO; O'REGAN JB; LIOANAG EM
Dis Nerv Syst; 1964 Apr; 25():221-4. PubMed ID: 14140033
[No Abstract] [Full Text] [Related]
13. MEDICAL AND SURGICAL TREATMENT OF PARKINSON'S DISEASE.
MARKHAM CH
Med Clin North Am; 1963 Nov; 47():1591-601. PubMed ID: 14078551
[No Abstract] [Full Text] [Related]
14. THE EFFECTS OF BIPERIDEN HYDROCHLORIDE (AKINETON) IN POST-ENCEPHALITIC PARKINSONISM.
MILLER V
Scott Med J; 1964 Sep; 9():391-3. PubMed ID: 14200166
[No Abstract] [Full Text] [Related]
15. [ON THE ANTAGONISM OF THE ACTION OF NEUROLEPTICS AND ANTIPARKINSON AGENTS].
ZSCHUCKE CF
Nervenarzt; 1964 May; 35():217-21. PubMed ID: 14182811
[No Abstract] [Full Text] [Related]
16. Benactyzine in patients with violent tempers and patients with Parkinsonism.
NATHAN PW
Br Med J; 1958 Apr; 1(5076):926-8. PubMed ID: 13523231
[No Abstract] [Full Text] [Related]
17. DRUGS FOR PARKINSONISM.
RICHARDSON JC
Can Med Assoc J; 1965 Apr; 92(17):928-9. PubMed ID: 14289143
[No Abstract] [Full Text] [Related]
18. [Mydocalm and muscle tone].
DOBI S
Ther Hung; 1961; 9():15-8. PubMed ID: 14028214
[No Abstract] [Full Text] [Related]
19. CALCIUM THERAPY IN DRUG-INDUCED PARKINSONISM.
LICHTIGFELD FJ
Br J Psychiatry; 1965 Feb; 111():197-8. PubMed ID: 14270533
[No Abstract] [Full Text] [Related]
20. [ON THE SIGNIFICANCE OF ASSOCIATED NEUROLOGIC DISORDERS IN TREATMENTS BY NEUROLEPTICS].
SIZARET P; CHALLOU C
Therapie; 1963; 18():1453-61. PubMed ID: 14117541
[No Abstract] [Full Text] [Related]
[Next] [New Search]
